Home » Topics » Disease categories and therapies » Dermatologic

Dermatologic
RSS

Apafant effective in UVB-induced dermatitis

July 16, 2003

Barrier Therapeutics licenses oral vitamin D3 derivative

July 15, 2003

Selective MMP-3 inhibitor as a candidate therapeutic for chronic dermal wounds

July 10, 2003

Amgen/Wyeth seek approval for fifth indication for anti-TNF therapy

July 9, 2003

GSK develops new glucocorticoid receptor agonists

July 9, 2003

Novel vitamin D analogues with utility in dermatological disorders designed at Galderma

July 8, 2003

Connetics submits NDA for Extina in seborrheic dermatitis

July 7, 2003

Liarozole granted E.U. orphan drug designation for congenital ichthyosis

July 4, 2003

Olux cleared for marketing in U.K.

July 3, 2003

Positive outcome for phase II study of Periostat as adjunctive treatment for rosacea

July 3, 2003

Popular Stories

Today's news in brief
BioWorld
ADPD 2026: Can we prevent dementia? Scientists quantify it
BioWorld
Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...
ADPD 2026: Three inflection points to target Alzheimer’s disease
BioWorld Science
A new way of understanding Alzheimer’s disease, based on biological inflection points that mark decisive moments in the progression of the disorder, could change...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
SERCA inhibitor from Sumitomo shows promise for MSA-C treatment
BioWorld Science
At the ongoing International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders (AD/PD 2026) in Copenhagen, Sumitomo Pharma Co....